High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature

The T cell compartment in patients with Crohn's disease is dysregulated. Here the authors use cytometric profiling to reveal an enrichment of distinct Tc17 cells during active Crohn's disease and may suggest CD6 as a potential target for therapeutic studies.

Bibliographic Details
Main Authors: A.-M. Globig, A. V. Hipp, P. Otto-Mora, M. Heeg, L. S. Mayer, S. Ehl, H. Schwacha, M. Bewtra, V. Tomov, R. Thimme, P. Hasselblatt, B. Bengsch
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-31229-z
_version_ 1811328520960344064
author A.-M. Globig
A. V. Hipp
P. Otto-Mora
M. Heeg
L. S. Mayer
S. Ehl
H. Schwacha
M. Bewtra
V. Tomov
R. Thimme
P. Hasselblatt
B. Bengsch
author_facet A.-M. Globig
A. V. Hipp
P. Otto-Mora
M. Heeg
L. S. Mayer
S. Ehl
H. Schwacha
M. Bewtra
V. Tomov
R. Thimme
P. Hasselblatt
B. Bengsch
author_sort A.-M. Globig
collection DOAJ
description The T cell compartment in patients with Crohn's disease is dysregulated. Here the authors use cytometric profiling to reveal an enrichment of distinct Tc17 cells during active Crohn's disease and may suggest CD6 as a potential target for therapeutic studies.
first_indexed 2024-04-13T15:27:35Z
format Article
id doaj.art-4b2e3af4e8874ad2adc7e59066cb9554
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-13T15:27:35Z
publishDate 2022-06-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-4b2e3af4e8874ad2adc7e59066cb95542022-12-22T02:41:28ZengNature PortfolioNature Communications2041-17232022-06-0113111510.1038/s41467-022-31229-zHigh-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signatureA.-M. Globig0A. V. Hipp1P. Otto-Mora2M. Heeg3L. S. Mayer4S. Ehl5H. Schwacha6M. Bewtra7V. Tomov8R. Thimme9P. Hasselblatt10B. Bengsch11Department of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgInstitute for Immunodeficiency, Center for Chronic Immunodeficiency, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgInstitute for Immunodeficiency, Center for Chronic Immunodeficiency, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine, Division of Gastroenterology, University of Pennsylvania Perelman School of MedicineDepartment of Medicine, Division of Gastroenterology, University of Pennsylvania Perelman School of MedicineDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgThe T cell compartment in patients with Crohn's disease is dysregulated. Here the authors use cytometric profiling to reveal an enrichment of distinct Tc17 cells during active Crohn's disease and may suggest CD6 as a potential target for therapeutic studies.https://doi.org/10.1038/s41467-022-31229-z
spellingShingle A.-M. Globig
A. V. Hipp
P. Otto-Mora
M. Heeg
L. S. Mayer
S. Ehl
H. Schwacha
M. Bewtra
V. Tomov
R. Thimme
P. Hasselblatt
B. Bengsch
High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature
Nature Communications
title High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature
title_full High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature
title_fullStr High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature
title_full_unstemmed High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature
title_short High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature
title_sort high dimensional profiling reveals tc17 cell enrichment in active crohn s disease and identifies a potentially targetable signature
url https://doi.org/10.1038/s41467-022-31229-z
work_keys_str_mv AT amglobig highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature
AT avhipp highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature
AT pottomora highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature
AT mheeg highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature
AT lsmayer highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature
AT sehl highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature
AT hschwacha highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature
AT mbewtra highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature
AT vtomov highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature
AT rthimme highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature
AT phasselblatt highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature
AT bbengsch highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature